text
"['\nX. 대주주 등과의 거래내용\n(1) 당반기 및 전반기 중 회사와 매출 등 거래 또는 채권, 채무 잔액이 있는 특수관계자 현황은 다음과 같습니다.\n관 계\n회 \xa0 \xa0 사 \xa0 \xa0 명\n종속기업\n㈜유한화학, ㈜유한메디카, ㈜와이즈메디, ㈜유한건강생활, YUHAN USA CORPORATION, YUHAN UZBEKISTAN, 애드파마㈜, YUHAN ANZ Pty Ltd., ㈜에이투젠, ㈜이뮨온시아, 에스비바이오팜㈜\n관계기업 및 공동기업\n유한킴벌리㈜, ㈜유한크로락스, ㈜한국얀센, ㈜유칼릭스, ㈜코스온, ㈜엔솔바이오사이언스,㈜씨.앤.씨, ㈜휴이노, ㈜메디오젠, ㈜제이인츠바이오, 메디라마㈜, ㈜프로젠, ㈜메리츠-수성글로벌바이오제1호\n기타특수관계자\n류신(칭다오)건강(유), (재)유한재단, ㈜리드팜, 주식회사 유, ㈜애니힐\n(2) 당반기 및 전반기 중 특수관계자와의 거래 내역은 다음과 같습니다.\n- 당반기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익 등)\n배당금수익\n매입 등\n기타매입\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n종속기업\n\xa0㈜유한화학\xa0\n2,880\n5,760\n-\n-\n-\n-\n-\n-\n69,613,828\n118,581,683\n-\n-\n\xa0㈜유한메디카\n218\n218\n6,900\n13,800\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0㈜와이즈메디\n-\n-\n8,970\n17,940\n-\n-\n-\n-\n5,297,526\n10,570,892\n-\n-\n\xa0㈜유한건강생활\n-\n-\n14,940\n29,880\n-\n5,270\n-\n-\n1,313,352\n2,368,641\n-\n-\n\xa0애드파마㈜\n-\n-\n-\n143,236\n-\n-\n-\n-\n6,056,614\n10,800,631\n-\n-\n\xa0㈜에이투젠\n-\n-\n-\n-\n-\n-\n-\n-\n1,503,918\n3,086,004\n-\n-\n\xa0에스비바이오팜㈜\n-\n-\n66,000\n135,600\n1,062\n2,152\n-\n-\n802,628\n1,860,520\n31,258\n31,258\n\xa0㈜이뮨온시아\n-\n-\n936\n1,872\n-\n198,524\n-\n-\n1,325,806\n1,325,806\n-\n-\n소 계\n3,098\n5,978\n97,746\n342,328\n1,062\n205,946\n-\n-\n85,913,672\n148,594,177\n31,258\n31,258\n관계기업 및 공동기업\n\xa0유한킴벌리㈜\n-\n-\n-\n-\n-\n-\n-\n25,500,000\n-\n17,047\n-\n-\n\xa0㈜유한크로락스\n-\n-\n442,891\n741,705\n1,882,765\n3,406,980\n-\n2,198,000\n24,296,765\n40,831,110\n-\n-\n\xa0㈜한국얀센\n-\n-\n-\n-\n-\n-\n-\n3,113,654\n10,234,857\n20,567,266\n-\n-\n\xa0㈜유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n21,324\n42,986\n-\n-\n\xa0㈜엔솔바이오사이언스\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n1,500,000\n\xa0㈜워랜텍(*)\n-\n-\n-\n-\n771,712\n771,712\n-\n-\n25,422\n95,877\n-\n-\n\xa0㈜씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,388,005\n2,646,352\n-\n-\n\xa0㈜휴이노\n-\n-\n-\n-\n-\n-\n-\n-\n1,083,750\n1,967,250\n-\n-\n\xa0㈜메디오젠\n-\n-\n-\n-\n-\n-\n-\n-\n255,506\n482,941\n-\n-\n\xa0㈜제이인츠바이오\n-\n-\n-\n-\n-\n-\n-\n-\n3,000,000\n3,000,000\n-\n-\n\xa0메디라마㈜\n-\n-\n22,169\n44,338\n-\n-\n-\n-\n-\n-\n-\n-\n소 계\n-\n-\n465,060\n786,043\n2,654,477\n4,178,692\n-\n30,852,454\n40,305,629\n69,650,829\n-\n1,500,000\n(기타특수관계자)\n\xa0(재)유한재단\n-\n-\n4,278\n8,556\n-\n-\n-\n-\n-\n-\n-\n1,000,000\n\xa0주식회사 유\n-\n-\n-\n-\n-\n-\n-\n-\n15,940\n32,065\n-\n-\n\xa0㈜애니힐\n-\n-\n-\n-\n-\n-\n-\n-\n63,680\n63,680\n-\n-\n\xa0㈜리드팜\n797,051\n1,381,773\n-\n-\n-\n-\n-\n-\n-\n1,460\n-\n-\n소 계\n797,051\n1,381,773\n4,278\n8,556\n-\n-\n-\n-\n79,620\n97,205\n-\n1,000,000\n합 계\n800,149\n1,387,751\n567,084\n1,136,927\n2,655,539\n4,384,638\n-\n30,852,454\n126,298,921\n218,342,211\n31,258\n2,531,258\n(*) 당반기 중 매각이 완료되기 전까지의 거래내역입니다.\n- 전반기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익등)\n배당금수익\n매입등\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n종속기업 :\n\xa0㈜유한화학\xa0\n1,800\n5,400\n-\n-\n-\n-\n-\n-\n50,460,666\n105,683,129\n\xa0㈜유한메디카\n218\n218\n118,654\n125,554\n-\n-\n-\n-\n-\n-\n\xa0㈜와이즈메디\n-\n-\n8,970\n17,940\n-\n-\n-\n-\n4,630,129\n9,379,595\n\xa0㈜유한건강생활\n-\n-\n221,464\n421,417\n-\n-\n-\n-\n2,554,486\n4,218,976\n\xa0애드파마㈜\n-\n-\n1,560\n3,120\n-\n-\n-\n-\n2,429,298\n3,451,057\n\xa0㈜에이투젠\n-\n-\n-\n-\n-\n-\n-\n-\n95,730\n795,730\n소 계\n2,018\n5,618\n350,648\n568,031\n-\n-\n-\n-\n60,170,309\n123,528,487\n관계기업 및 공동기업 :\n\xa0㈜유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n21,324\n43,163\n\xa0㈜유한크로락스\n2,755\n2,755\n488,751\n772,885\n1,092,658\n1,999,311\n-\n1,868,300\n21,282,017\n36,054,297\n\xa0유한킴벌리㈜\n-\n-\n-\n-\n-\n-\n-\n20,700,000\n-\n-\n\xa0㈜한국얀센\n-\n-\n-\n62,442\n-\n-\n-\n5,529,000\n10,571,879\n21,012,801\n\xa0㈜이뮨온시아\n-\n-\n936\n1,872\n-\n-\n-\n-\n-\n-\n\xa0파라투스에스피사모투자(합)(*)\n-\n-\n-\n-\n-\n-\n6,631,427\n6,631,427\n-\n-\n\xa0㈜씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,663,494\n3,466,171\n\xa0㈜워랜텍\n-\n3,680\n-\n-\n-\n-\n-\n-\n1,323,075\n1,960,702\n\xa0㈜지아이이노베이션\n-\n-\n-\n-\n3,243,500\n3,633,500\n-\n-\n-\n-\n\xa0㈜휴이노\n-\n-\n-\n-\n-\n-\n-\n-\n(9,750)\n(12,750)\n\xa0㈜메디오젠\n-\n-\n-\n-\n-\n-\n-\n11,728\n627,011\n1,032,558\n\xa0에스비바이오팜㈜\n-\n-\n76,800\n153,600\n1,300\n1,300\n-\n-\n618,561\n1,361,822\n\xa0메디라마㈜\n-\n-\n22,187\n44,174\n-\n-\n-\n-\n-\n20,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n2,755\n6,435\n588,674\n1,034,973\n4,337,458\n5,634,111\n6,631,427\n34,781,255\n36,097,611\n64,938,764\n기타특수관계자 :\n\xa0㈜리드팜\n660,973\n1,178,057\n-\n-\n-\n-\n-\n-\n-\n992\n\xa0류신(칭다오)건강(유)\n-\n-\n-\n-\n-\n-\n-\n-\n16\n111\n소 계\n660,973\n1,178,057\n-\n-\n-\n-\n-\n-\n16\n1,103\n합 계\n665,746\n1,190,110\n939,322\n1,603,004\n4,337,458\n5,634,111\n6,631,427\n34,781,255\n96,267,936\n188,468,354\n(*) 관계기업에 제외되기 전까지의 거래내역입니다.\n(3) 당반기말과 전기말 현재 특수관계자와의 채권ㆍ채무는 다음과 같습니다.\n\xa0(단위:천원)\n회사명\n매출채권\n매입채무\n미수금 등 기타자산\n예수보증금\n대여금\n당반기말\n전기말\n당반기말\n전기말\n당반기말\n전기말\n당반기말\n전기말\n당반기말\n전기말\n(종속기업)\n\xa0㈜유한화학\xa0\n-\n1,980\n28,354,552\n3,735,203\n-\n9,900,971\n-\n-\n-\n-\n\xa0㈜유한메디카\n-\n-\n-\n-\n-\n-\n400,000\n400,000\n-\n-\n\xa0㈜와이즈메디\n-\n-\n2,374,284\n3,405,379\n1,400,000\n1,400,000\n520,000\n520,000\n-\n-\n\xa0㈜유한건강생활\n5,478\n5,478\n1,424,800\n999,163\n-\n-\n796,800\n796,800\n-\n-\n\xa0YUHAN UZBEKISTAN\n793,099\n736,123\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0애드파마㈜\n-\n-\n-\n1,634,408\n1,668,207\n2,492,082\n-\n-\n-\n-\n\xa0㈜에이투젠\n-\n-\n831,374\n1,107,634\n-\n-\n-\n-\n-\n-\n\xa0㈜이뮨온시아\n343\n-\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0에스비바이오팜㈜\n-\n-\n-\n-\n10,619,754\n7,745,818\n225,000\n250,000\n93,000\n93,000\n소 계\n798,920\n743,581\n32,985,010\n10,881,787\n13,687,961\n21,538,871\n1,941,800\n1,966,800\n93,000\n93,000\n(관계기업 및 공동기업)\n\xa0㈜유한크로락스\n487,180\n433,330\n26,726,441\n24,110,868\n1,349,216\n1,438,256\n-\n-\n-\n-\n\xa0㈜한국얀센\n-\n-\n7,523,663\n7,181,019\n-\n-\n-\n-\n-\n-\n\xa0㈜유칼릭스\n-\n-\n4,401\n3,758\n-\n-\n-\n-\n-\n-\n\xa0㈜코스온\n-\n-\n-\n-\n-\n2,043,540\n-\n-\n-\n-\n\xa0㈜씨.앤.씨\n-\n-\n1,524,383\n2,121,987\n-\n-\n-\n-\n-\n-\n\xa0㈜워랜텍\n-\n-\n-\n398,141\n-\n-\n-\n-\n-\n-\n\xa0㈜지아이이노베이션\n-\n-\n-\n-\n-\n1,058,301\n-\n-\n-\n-\n\xa0㈜휴이노\n-\n-\n275,000\n275,000\n-\n-\n-\n-\n-\n-\n\xa0㈜메디오젠\n-\n-\n280,885\n694,931\n-\n-\n-\n-\n-\n-\n\xa0메디라마㈜\n-\n-\n-\n-\n-\n-\n42,000\n42,000\n-\n-\n소 계\n487,180\n433,330\n36,334,773\n34,785,704\n1,349,216\n4,540,097\n42,000\n42,000\n-\n-\n(기타특수관계자)\n\xa0(재)유한재단\n-\n-\n-\n-\n-\n-\n248,000\n248,000\n-\n-\n\xa0㈜리드팜\n773,479\n391,291\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0주식회사 유\n-\n-\n4,425\n1,485\n-\n-\n-\n-\n-\n-\n\xa0㈜애니힐\n-\n-\n31,570\n12,595\n-\n-\n-\n-\n-\n-\n소 계\n773,479\n391,291\n35,995\n14,080\n-\n-\n248,000\n248,000\n-\n-\n합 계\n2,059,579\n1,568,202\n69,355,778\n45,681,571\n15,037,177\n26,078,968\n2,231,800\n2,256,800\n93,000\n93,000\n(4) 당반기 및 전반기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.\n(단위: 천원)\n특수관계 구분\n회사명\n당반기\n전반기\n회수\n출자\n출자\n종속기업\n㈜에이투젠\n-\n5,000,008\n7,000,069\nYUHAN USA CORPORATION\n-\n3,911,400\n-\n에스비바이오팜㈜\n-\n7,742,202\n-\nYUHAN ANZ Pty Ltd.\n-\n321,325\n-\n관계기업 및 공동기업\n㈜코스온\n-\n5,541,363\n-\n메디라마㈜\n-\n-\n1,499,971\n㈜메디오젠\n4,925,020\n-\n-\n㈜프로젠\n-\n6,000,003\n29,998,329\n㈜메리츠-수성 글로벌바이오제1호\n-\n-\n2,000,000\n(5) 당반기말 현재 회사가 특수관계자에게 제공한 지급보증 및 담보 내역은 다음과 같습니다.\n(단위: 천원)\n회사명\n보증 등의 내용\n금융기관\n보증 금액\n(종속기업)\n㈜유한건강생활\n일반대출\n신한은행\n3,600,000\n애드파마㈜\n운전자금대출\n하나은행\n6,000,000\n합 \xa0계\n9,600,000\n(6) 회사는 등기이사 및 회사 기업활동의 계획, 운영 및 통제에 대한 중요한 권한과 책임을 가진 등기 임원을 주요 경영진으로 판단하고 있으며, 당반기 및 전반기 중 주요 경영진에 대한 보상금액은 다음과 같습니다.\n(단위:천원)\n구 \xa0분\n당반기\n전반기\n3개월\n누적\n3개월\n누적\n단기종업원급여\n578,359\n984,140\n473,878\n1,118,802\n퇴직급여\n84,752\n149,283\n72,558\n145,117\n합 계\n663,111\n1,133,423\n546,436\n1,263,919\n']"
